RARE

NASDAQ · Biotechnology

Ultragenyx Pharmaceutical In

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$15.62

-1.54 (-8.97%)

As of Nov 5, 8:51 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 16 62%

Hold 10 38%

Sell 0 0%

Price Target

Analyst Price Target +376.6% upside

Low Target $68.49

Average Target $74.44

High Target $103.74

Current Price $15.62

Current
$15.62

Target
$74.44

$68.49 $74.44 avg $103.74

Scenario Analysis

Bear Case

$68.49

338.5%

Low target

Base Case

$74.44

+376.6%

Avg target

Bull Case

$103.74

+564.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$39.89

-60.8% from high

52-Week Low

$12.73

+22.7% from low

50-Day SMA

$16.45

-5.0% vs SMA

200-Day SMA

$22.80

-31.5% vs SMA

RSI (14)

65.9

Neutral

Target vs 52W High

$74.44

+86.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%